Literature DB >> 25457879

MicroRNAs are implicated in the suppression of CD4+CD25− conventional T cell proliferation by CD4+CD25+ regulatory T cells.

Sha Zhou1, Xiaoxiao Dong, Cui Zhang, Xiajun Chen, Jifeng Zhu, Wei Li, Xian Song, Zhipeng Xu, Weiwei Zhang, Xiaowei Yang, Yong Li, Feng Liu, Chuan Sun.   

Abstract

CD4+CD25+ regulatory T cells (Tregs) are critical for sustaining immunological homeostasis. CD4+CD25− conventional T cells (Tcons) are the progenitors of populations including Th1, Th2, Th17, Tfh, and Treg cells. Suppression of Tcons proliferation by Tregs requires cell–cell contact and/or is mediated by immunosuppressive soluble factors. However, upon receiving suppressive signals from Tregs, the exact molecular responses in Tcons remain elusive. Here, by using microRNA (miRNA) microarray preliminary screening and quantitative RT-PCR (qRT-PCR) validation, we showed that paralleled with the suppression of the Tcons proliferation, miR-146a was induced but miR-106b and miR-21 were reduced in Tcons upon receiving suppressive signals from Tregs. Moreover, our results showed that either increase of miR-146a or decrease of miR-106b and miR-21 by using miRNA mimics or inhibitors in Tcons significantly enhanced the suppression triggered by Tregs. However, decrease of miR-146a or increase of miR-106b and miR-21 in Tcons impaired the suppression triggered by Tregs. Collectively, our findings demonstrate the roles of miR-146a, miR-106b and miR-21 in Tcons in regulating Treg-triggered immune-suppression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25457879     DOI: 10.1016/j.molimm.2014.10.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  MicroRNA-146a contributes to CD4+ T lymphocyte differentiation in patients with thyroid ophthalmopathy.

Authors:  Wen-Juan Yang; Peng-Fei Ma; Shu-Ping Li; Hong Su; Yun-Jia Liu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

2.  Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Authors:  Adrien Costantini; Catherine Julie; Coraline Dumenil; Zofia Hélias-Rodzewicz; Julie Tisserand; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Etienne Giroux Leprieur
Journal:  Oncoimmunology       Date:  2018-04-20       Impact factor: 8.110

3.  CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel.

Authors:  Yvonne Schmiedel; Ghyslain Mombo-Ngoma; Lucja A Labuda; Jacqueline J Janse; Brechje de Gier; Ayôla A Adegnika; Saadou Issifou; Peter G Kremsner; Hermelijn H Smits; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2015-08-20

4.  The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.

Authors:  Kun He; Ping Liu; Lisa X Xu
Journal:  Cell Death Dis       Date:  2017-03-23       Impact factor: 8.469

5.  miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.

Authors:  Iwona Bronisz-Budzyńska; Katarzyna Chwalenia; Olga Mucha; Paulina Podkalicka; Alicja Józkowicz; Agnieszka Łoboda; Magdalena Kozakowska; Józef Dulak
Journal:  Skelet Muscle       Date:  2019-08-14       Impact factor: 4.912

Review 6.  miRNA-Dependent CD4+ T Cell Differentiation in the Pathogenesis of Multiple Sclerosis.

Authors:  Justyna Basak; Ireneusz Majsterek
Journal:  Mult Scler Int       Date:  2021-01-08

Review 7.  MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders.

Authors:  Xue Bai; Zhigang Bian
Journal:  Front Mol Neurosci       Date:  2022-01-31       Impact factor: 5.639

Review 8.  Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes.

Authors:  Himadri Devvanshi; Rohit Kachhwaha; Anima Manhswita; Shinjini Bhatnagar; Pallavi Kshetrapal
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 9.  Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid.

Authors:  Mohsen Karami Fath; Jalil Azami; Niloofar Jaafari; Mahsa Akbari Oryani; Nafiseh Jafari; Alireza Karim Poor; Ali Azargoonjahromi; Mohsen Nabi-Afjadi; Zahra Payandeh; Hamidreza Zalpoor; Dariush Shanehbandi
Journal:  Cell Mol Biol Lett       Date:  2022-09-05       Impact factor: 8.702

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.